New York, October 08, 2021 – Reports and Data has published its latest report titled “bioburden testing market By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma), By Application (Surgery, Radiology, Chemotherapy, Immunotherapy, Targeted Drug Therapy), And By End-Use, Forecasts To 2028.”
Increasing awareness regarding biological safety practices, rising food safety standards, and continuous technological developments in pharmaceutical and biotechnology sector are some key factors driving market growth
Download sample @ https://www.reportsanddata.com/sample-enquiry-form/2494
According to Reports and Data, the global bioburden testing market size is expected to reach USD 1,611.8 million in 2028 and register a revenue CAGR of 12.3% during the forecast period, 2021-2028.
Drivers, Restraints, and Opportunities
Bioburden testing, or total viable count testing, is the measure of microbial contamination levels on or in a product. Bioburden testing is used for medical devices, raw materials, pharmaceuticals, packaging, animal tissue, human tissue, and cosmetics.
Ongoing research and development activities and technological advancements in the healthcare industry along with the government and private investments to promote bioburden testing tools are some factors expected to positively impact revenue growth of the market over the forecast period. In addition, growing awareness regarding bioburden testing services, and increasing awareness regarding regular medical checkups are some other key factors contributing to the revenue growth of the market.
However, high cost of enumeration instruments including maintenance costs and high-content screening, stringent regulatory framework, and availability of conventional methods for the enumeration of viable microorganisms are some major factors expected to restrain global bioburden testing market revenue growth over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Pharmaceutical Ingredients Application Type to Account for Largest Revenue Share:
Pharmaceutical ingredients segment is expected to account for largest revenue share in the global market over the forecast period attributed to rising uptake of biopharmaceuticals, increase in manufacturing of drugs and supportive government policies.
Contract Research Organization (CRO) Segment to Dominate Other End Use Segment:
Contract Research Organization (CRO) segment is expected to dominate other end use segment over the forecast period attributed rising government and private investments on biopharmaceutical research for advancements in healthcare sector.
To know more about the report @ https://www.reportsanddata.com/report-detail/bioburden-testing-market
North America to Account for a Significantly Large Revenue Share:
North America is expected to account for a significantly large revenue share over the forecast period owing to ongoing technological advancements in healthcare system that makes accessing bioburden testing much easier, advancements on medical devices, and availability of government financial aids. Further, development of new U.S. vaccinations, biologics, and medicines and drugs creates demand for bioburden testing services.
Asia Pacific to Lead in Terms of Revenue CAGR:
Asia Pacific market revenue is expected to expand at a robust revenue CAGR over the forecast period attributed to rapid expansion of the R&D activities, rapid urbanization, and rising technological advancements in pharmaceutical and biotechnology industries. In addition, rapid growth of healthcare clinics especially in emerging economies (such as India and China), where hospitalization is at large scale due to increasing prevalence of chronic diseases, drive revenue growth of the APAC market.
Major Companies in the Market Include:
- Charles River Laboratories
- Merck KGaA
- SGS SA
- Thermo Fisher Scientific
- Biomérieux SA
- Pacific Biolabs
- Wuxi Apptec
- STERIS Laboratories
- Nelson Laboratories LLC
- Sartorius AG
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2494
Market Segmentation:
For the purpose of this report, Reports and Data has segmented the global bioburden testing market on the test method, application, end use and region:
Test Method Outlook (Revenue in Million USD; 2020–2028)
- Automated Detection of Growth
- Instrument
- Reagent/Kits
- Consumables & Accessories
- Software
- Staining
- Instrument
- Reagent/Kits
- Consumables & Accessories
- Software
- Autofluorescence I
- Instrument
- Reagent/Kits
- Consumables & Accessories
- Autofluorescence II
- Instrument
- Reagent/Kits
- Consumables & Accessories
- ATP-Bioluminescence
- Instrument
- Reagent/Kits
- Consumables & Accessories
- Software
- Cytometry
- Instrument
- Reagent/Kits
- Consumables & Accessories
Application Outlook (Revenue in Million USD; 2020–2028)
- Raw Materials
- Process Water
- Pharmaceutical Ingredients
- Process Equipment
- Manufacturing Personnel
- Manufacturing Environmental Monitoring
- Heating System
- Ventilation System
- Air-Conditioning System
- Packaging/Bulk Finished Products
End Use Outlook (Revenue in Million USD; 2020–2028)
- Biopharmaceutical & Pharmaceutical Companies
- Contract Research Organization (CRO)
- Contract Manufacturing Organization (CMO)
- Cell Banks
- Academic Research Institutes
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.E.A
- South Africa
- Israel
- Rest of MEA
Buy Now Premium Research Report – https://www.reportsanddata.com/checkout-form/2494
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Similar Research reports by Reports and Data of Pharma and Healthcare Industry:
Colorectal Cancer Market Size, Share And Industry Analysis By Product-based (In situ Hybridization, Flow Cytometry, Next-generation Sequencing, Microarrays, Chemotherapy, Immunotherapy, Targeted therapy), By Procedure (Biopsy, Mammography, Colostomy, Sigmoidoscopy, MRI) And Region, Segment Forecasts To 2026 Download PDF Brochure
Erythropoietin (EPO) Drugs Market Size, Share & Trends Analysis Report By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa & Others), By Application, By Region, Competitive Strategies and Segment Forecasts to 2016-2026 Download PDF Brochure
Foot and Mouth Disease (FMD) Vaccine Market Share & Trends Analysis Report By Type (Conventional Vaccines, Emergency Vaccines), By Application, By Region, Competitive Strategies and Segment Forecasts to 2016-2026 Download PDF Brochure
Etanercept Market Size by Product (Enbrel, Benepali), by Application (Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Juvenile idiopathic arthritis (JIA) and Others), Share & Trends Analysis Report By Region, Competitive Strategies and Segment Forecasts to 2016-2026 Download PDF Brochure
Fluoxetine Market Size by Type (Tablets, Capsules, Oral Solutions), by Application (Depression, Obsessive-Compulsive Disorder, Panic disorder, Bulimia Nervosa and Others), Share & Trends Analysis Report By Region, Competitive Strategies and Segment Forecasts to 2016-2026 Download PDF Brochure
About Reports and Data:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-bioburden-testing-market